KalVista Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
KalVista Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q2 2024.
  • KalVista Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending July 31, 2024 was $3.04M, a 6.58% decline year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $21.9M, a 121% increase from 2022.
  • KalVista Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9.92M, a 10.5% decline from 2021.
  • KalVista Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11.1M, a 55.7% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $3.04M -$214K -6.58% May 1, 2024 Jul 31, 2024 10-Q 2024-09-05
Q2 2023 $3.25M +$612K +23.2% May 1, 2023 Jul 31, 2023 10-Q 2024-09-05
Q2 2022 $2.64M -$153K -5.47% May 1, 2022 Jul 31, 2022 10-Q 2023-09-07
Q2 2021 $2.8M +$1.61M +135% May 1, 2021 Jul 31, 2021 10-Q 2022-09-08
Q2 2020 $1.19M +$114K +10.6% May 1, 2020 Jul 31, 2020 10-Q 2021-09-09
Q2 2019 $1.07M +$727K +210% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q2 2018 $347K +$126K +57% May 1, 2018 Jul 31, 2018 10-Q 2019-09-09
Q2 2017 $221K -$91K -29.2% May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
Q3 2016 $1.3M $282K -$7K -2.42% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-08
Q2 2016 $1.31M $312K +$275K +743% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-12
Q1 2016 $1.04M $368K +$250K +212% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-12
Q4 2015 $785K $341K +$169K +98.3% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-30
Q3 2015 $616K $289K +$189K +189% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $427K $37K -$13K -26% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 $440K $118K +$59K +100% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 $381K $172K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 $100K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $50K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $59K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.